Androgen associated hepatocellular carcinoma with an aggressive course.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1655591.
- Also identified by PMC identifier 1379057.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The hepatocellular carcinomas that develop in patients treated with androgens have previously been associated with a benign clinical outcome. We describe a man who developed a hepatocellular carcinoma after 24 years of androgen treatment, whose tumour initially showed partial regression after withdrawal of androgens but subsequently pursued an aggressive and fatal course.
Medical subject headings
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Methyltestosterone